Ocular Therapeutix, Inc.
OCUL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$194 | -$81 | -$71 | -$7 |
| Dep. & Amort. | $4 | $3 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $33 | $18 | $17 | $15 |
| Change in WC | -$10 | -$7 | $1 | -$3 |
| Other Non-Cash | $32 | -$3 | -$9 | -$73 |
| Operating Cash Flow | -$135 | -$70 | -$60 | -$66 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$6 | -$4 | -$1 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$6 | -$4 | -$1 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $316 | $56 | $0 | -$0 |
| Stock Issued | $316 | $118 | $1 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$301 | -$5 | $1 | $2 |
| Financing Cash Flow | $332 | $170 | $1 | $3 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $196 | $94 | -$62 | -$64 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $198 | $104 | $166 | $230 |
| End Cash | $394 | $198 | $104 | $166 |
| Free Cash Flow | -$136 | -$76 | -$63 | -$67 |